Featured Research

from universities, journals, and other organizations

New model tracks the immune response to a T

Date:
April 10, 2010
Source:
Whitehead Institute for Biomedical Research
Summary:
Researchers have created novel mouse models of the immune system starting with T cells primed for the infectious disease toxoplasmosis by generating cloned mice from these T cells. This type of model more accurately represents how immune cells respond to infectious diseases, and could be used to more reliably study immune cell biology and the role of immune cells in infectious disease. Earlier immune system models are inherently limited by the laboratory procedure involved.

Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.

"These models have a lot of potential," says Oktay Kirak, who is a postdoctoral researcher in the labs of Whitehead Members Hidde Ploegh and Rudolf Jaenisch. "It allows us to study both the biology of T cells as well as their role in toxoplasmosis."

Toxoplasma gondii, the single-celled parasite that causes toxoplasmosis with more than 30% of humans infected, the symptoms are generally minor, although toxoplasmosis can have serious or fatal effects for an immunocompromised person or a fetus, if the mother is infected during pregnancy.

In the April 9 issue of Science, Kirak and his colleagues describe how he used somatic cell nuclear transfer (SCNT) to create mice from single T cells that recognize the Toxoplasma gondii parasite.

In SCNT, a cell's nucleus is inserted into a de-nucleated, unfertilized egg cell to generate embryonic stem cells and animals with the same genetic code. In this study, Kirak, who is first author of the Science paper, transferred the nucleus of a T cell primed for toxoplasmosis into an enucleated, unfertilized mouse egg to create mice.

Kirak used T cells -- a class of white blood cells that include several types of cells including cytotoxic or so-called killer T cells -- because they have been difficult to study in current immune system models. Each cytotoxic T cell has its genetic material rearranged, so that it produces properly activated a receptor that can identify an antigen. An antigen is a particular part of an infectious agent, such as a virus, bacterium, or parasite, that the immune system can recognize. Once properly activated by the relevant antigen, the cytotoxic T cell will then kill any cell that is infected with that pathogen.

Many T cells may respond to a particular infectious agent, such as Toxoplasma gondii and they all may recognize different antigens on the parasite's surface. This multiple-pronged attack, though highly beneficial in eliminating infectious agents, complicates the study of specific T cell's interactions with the antigen and infectious agent. Kirak's method solves this problem by creating a mouse with identical T cells and activating them in the course of infection.

"Kirak's work was a really imaginative application of the nuclear transfer technique: to create a mouse with defined and predictable immunological properties, which will be useful for studying infectious diseases," says Jaenisch, who is also a professor at MIT.

This is a unique approach for immune system models. Some earlier models rely on transgenic mice in a process that leaves indelible marks created by the experiment itself and depend on a researcher subjectively choosing the mouse with the "best" immune response. Other models trick the infectious agent into producing a surrogate protein, not usually produced by that pathogen, like a protein found in egg whites. A researcher then documents how immune cells that recognize the egg white protein "respond" to the infectious agent. This model has serious drawbacks because T cells can respond at different times to different antigens during a natural infection.

In contrast to these models, SCNT generates T cell mouse models, with minimal tampering by the researcher and that depend entirely on the natural course of events. And that is an important advance for immune system models.

"The opportunity to look at true pathogen-derived antigens in the course of a natural infection provides us with a new window on how the immune system operates," says Ploegh, who is also a professor at MIT. "There's no current model that even comes close to this, by my reckoning."

This research was supported by a donation from Landon Clay.


Story Source:

The above story is based on materials provided by Whitehead Institute for Biomedical Research. The original article was written by Nicole Giese. Note: Materials may be edited for content and length.


Journal Reference:

  1. Oktay Kirak, Eva-Maria Frickel, Gijsbert M. Grotenbreg, Heikyung Suh, Rudolf Jaenisch, and Hidde L. Ploegh. Transnuclear Mice with Predefined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT. Science, 2010; 328 (5975): 243 DOI: 10.1126/science.1178590

Cite This Page:

Whitehead Institute for Biomedical Research. "New model tracks the immune response to a T." ScienceDaily. ScienceDaily, 10 April 2010. <www.sciencedaily.com/releases/2010/04/100408160856.htm>.
Whitehead Institute for Biomedical Research. (2010, April 10). New model tracks the immune response to a T. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100408160856.htm
Whitehead Institute for Biomedical Research. "New model tracks the immune response to a T." ScienceDaily. www.sciencedaily.com/releases/2010/04/100408160856.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins